Dr. Miller’s Presentations

By State/Area  [By Audience Type]

Talk Map June 2021
Washington DC Area or National

  • Guest on Podcast: “CareTalk with Quick and Quack“ with Dr. Evan Benjamin and Dr. Bill Cutler, May 24, 2024. Podcast Link Here
  • “How to promote confidence in vaccines (and undo misinformation) in your social circle & community” World Vaccine Congress, Washington, DC, April 4, 2024
  • Moderator, “Fireside chat: how the infodemic of misinformation on social media is affecting vaccine perceptions and uptake” with Dr Katrine Wallace, Epidemiologist, University of Illinois Chicago; and Dr Anita Patel, Pediatrician, Children’s National Hospital, World Vaccine Congress, Washington, DC, April 4, 2024
  • Chair, Vaccine Safety Sessions, including “Panel: Strategies for building successful trusted messaging around vaccines,” with Emily Acker, BIO; Synovia Moss, NCNW Good Health WINs, Lauren Rauh, CUNY School of Public Health Foundation; Reginald Ware, CEO, BlackDoctor.org; Burton Eller, The National Grange; and Amy Elizondo, National Rural Health Association, World Vaccine Congress, Washington, DC, April 4, 2024
  • World Vaccine Congress, Chair, Day of Market Access Sessions, Washington, DC, April 5, 2023
  • “Vaccine & Science Misinformation,” AAAS Fellows STEAM Team Talk, September 28, 2022 (Virtual)
  • “Communicating Value and Evidence about Innovations,” AdvaMed’s Reimbursement 201 Workshop, April 26, 2022 (Virtual)
  • “How have we made progress in the fight against scientific misinformation,” Moderator of Panel at World Vaccine Congress, Washington DC, April 20, 2022, with Peter Hotez, Dean, National School of Tropical Medicine; Rupali Limaye, Director of Behavioral and Implementation Science, JHU; Hussain Lalani, Co-Founder, ThisIsOurShot – VacunateYa and Primary Care Doctor, Brigham and Women’s Hospital; David A. Broniatowski, Director, Decision Making and Systems Architecture Laboratory, George Washington University
  • “Conversation about COVID-19 and Immunizations,” Discussion with Employees at QTC Management (a Leidos Company), October 26, 2021 (Virtual)
  • “What is Long-COVID,” Why We Vax VaxTalk video, May 17, 2021
  • “Vaccinating Against Misinformation,” World Vaccine Congress Panel with Angus Thomson, Senior Social Scientist, Demand for Immunization, UNICEF; Joe Smyser, Founder & CEO, Public Good Projects; Renée DiResta, Research Manager, Stanford Internet Observatory; Bruce Gellin, President of Global Immunization Sabin Vaccine Institute; Peter Hotez, Dean, National School of Tropical Medicine; and Jacquelyn Mason, Senior Investigative Researcher & Special Projects Manager at First Draft, May 6 , 2021
  • “COVID-19 Where We Are Now: Where We Are Going,” Why We Vax VaxTalk Roundtable, May 4, 2021
  • “Countering Vaccine Misinformation on Social Media,” Presentation to National Vaccine Advisory Committee, Vaccine Confidence Subcommittee, January 5, 2021
  • “If people won’t take vaccine, we’ll get back to normal very slowly,” Just the News Podcast about Vaccines, December 9, 2020 (Interview starts at timecode 16:45)
  • “COVID-19 Vaccine Outlook: Promises and Uncertainties,” FairTrade America Staff, August 19, 2020
  • Roundtable Participant, Personalize Medicine Coalition PCORI Project, “Moving Beyond Population Averages: A Patient-Centered Research Agenda Advancing Personalized Medicine,” August 2020
  • Moderated Panels and Discussions at HealthyWomen’s Biosmilars and Women’s Health Science and Policy Forum, September 25, 2019
  • Moderated HealthyWomen’s Corporate Advisory Board’s Annual Meeting Policy Discussions about Women’s Health in 2020, October 17. 2019
  • Moderator, HealthyWomen Science, Technology and Innovation Roundtable: Migraines Therapies in Women, “Barriers to non-invasive non-drug treatments” panel, December 14, 2018
  • Participant, “Can New Industry Partnerships Reshape the US Healthcare System?,” Brandeis University’s Health Industry Forum, Washington, DC, December 5, 2018
  • Moderated HealthyWomen’s Corporate Advisory Board’s Annual Meeting Policy Discussions about Access Issues and Women’s Health, October 19, 2018
  • Keys to Expanding Medication?Assisted Treatment for Opioid Addiction: State Strategies to Advance Reform,” Women In Government 9th Annual Health Care Summit, October 5, 2018
  • “Health Policy Issues,” Health Policy Class Discussion (MPO 1002 & GSN 712), Uniformed Services University of the Health Sciences, Bethesda, MD, August 3, 2018
  • Participant, “Paying for the Next Generation of Innovative Therapies”, Brandeis University’s Health Industry Forum, Washington, DC, June 13, 2018
  • “Developing Evidence and Making the Case for Coverage,” AdvaMed Medical Reimbursement 201 Workshop, June 28, 2017
  • “Shaping the Policy Agenda for Access to Care for Women with Heart Disease,” Keynote at KOLs Workshop on Access to Care for Women with Heart Disease organized by WomenHeart, April 5, 2017
  • Participant, “Healthcare Cost Control: What Is The Path Forward?”, Brandeis University’s Health Industry Forum, Washington, DC, March 14, 2018
  • “Framework for the Future of the U.S. Healthcare System: What Comes After ObamaCare?,” HealthyWomen Networking Breakfast, Washington, DC, February 14, 2017
  • “Health Reform in 2014: Opportunities & Challenges for Physicians,” Medical Society of Alabama, Washington, DC, February 10, 2014
  • Caffeine in Foods: Issues and Perspectives for Consumers, FDA Presentation, June 11, 2013
  • “Employer Perspectives on Health Promotion and Disease Prevention,” Georgetown University, February 14, 2013
  • “Genetics, Literacy and Data Collection/Monitoring in Health Disparities,” George Washington University School of Public Health, PubH376: Understanding and Eliminating Health Disparities, October 20, 2009
  • “Health Benefits Laws & Legislation,” George Washington University School of Law, “Employment Law,” Washington, DC, November 10, 2003
  • Briefing Moderator, “The Long Road to Discovery: The Challenging Search for New Cures for Cancer,”  Washington, DC, June 24, 2003
  • Fox Cable News, “Purchasing Medicines from Canada,” January 14, 2003
  • “Prescription Drugs, Prices and TV Ads,” National Public Radio, “Talk of the Nation,” April 9, 2002 [listen from NPR audio]
  • Participant, “Science and Technology for National Security: The Next 50 Years,” Center for Global Security Research: Lawrence Livermore National Laboratory, Arlington, VA May 7-8, 2002
  • “Pharmaceutical Innovation & Issues,” The New England Council Congressional Staff Briefing, 1116 Longworth House Office Building, Washington, DC, January 30, 2002
  • “Pharmaceutical Issues in Washington – The Industry View,” American Osteopathic Association Council on Federal Health Programs, Washington, DC, January 18, 2002
  • Testimony Before the United States Senate’s Committee on Veterans’ Affairs, Hearing on Prescription Drug Issues in the Department of Veterans Affairs, July 24, 2001
  • “Pharmaceutical Industry Issues,” Georgetown Policy & Business in Medicine Seminar, Georgetown University School of Medicine, January 12, 2001
  • “Utilizing Manufacturer Patient Assistance Programs: New Industry Efforts and Provider Feedback,” 340B Coalition Annual Conference, Washington, DC, July 20, 2000
  • “Access to Prescription Drugs, Pharmaceutical Research & Quality Healthcare,” Northern Virginia Access to Health Care Consortium, Annandale, VA, May 25, 2000
  • “Quality Health Care: The Right Drug for the Right Patient at the Right Time,” Foundation for Veterans’ Healthcare, “Veterans Healthcare: A New Millennium, A New Administration, A New Approach?” Washington, DC, May 11, 2000
  • “It’s About Coverage, Not Price,” Public Relations Society of America Health Academy Meeting “Improved Health Care: At What Cost?,” Washington, DC, April 13, 2000
  • “The Value of Innovation – For Patients, the Health Care System, and Society,” Public Relations Society of America Health Academy Meeting “Improved Health Care: At What Cost?” Washington, DC, April 13, 2000
  • “Medicare & Prescription Drugs,” National Alliance for the Mentally Ill Legislative and Leadership Conference, Washington, DC, February 7, 2000

Alabama

  • “MCH and Health Reform in the States: Activities and Opportunities,” University of Alabama Birmingham, The Lister Hill Center for Health Policy & The Alabama Maternal & Child Health (MCH) Leadership Network, October 24, 2013

Arizona

  • “Epigenetics and Regulating Genes: Implications for MCH in Arizona,” Arizona Improving Birth Outcomes Summit, Phoenix, AZ, January 7, 2014
  • “Prescription Drugs – Overview & Updates,” John C. Lincoln Health Network and Medical Staff Retreat, Sedona, AZ, June 3, 2000

Arkansas

  • “Pharmaceuticals: Access, Costs and Other Issues,” Arkansas Society of the American College of Osteopathic Family Physicians, Hot Springs, AR, March 21, 2002

California

  • “Tele-ICU Technology Profile,” Presentation to New England Healthcare Institute’s FAST Initiative Steering Committee, San Francisco CA, May 11, 2006
  • Participant, “The Biological Challenge: Exploiting the Opportunities and Managing the Risks” Center for Global Security Research; Chemical, Biological Arms Control Institute; International Institute for Strategic Studies, Lawrence Livermore National Laboratory, April 11-12, 2002
  • Participant, “Science and Technology for National Security: The Next 50 Years,” Center for Global Security Research: Lawrence Livermore National Laboratory, March 12-13, 2002
  • “Pharmaceutical Industry Issues: Access, Costs, R&D, and Information,” The Forum for Medical Affairs, AMA House of Delegates Meeting, San Francisco, CA, December 3, 2001
  • “Global Access to Affordable Treatment: The Current Medications Controversy,” 13th Annual HIV/AIDS Update Conference, San Francisco, CA, March 23, 2001

Florida

  • “State Leadership Retreats: Multi-Stakeholder Alignment,” NAIC’s Health Care Reform Alternatives Working Group, Orlando, FL, March 30, 2014
  • “Finding Cures for Heart Disease Through Innovative Pharmaceutical Research,” Nova Southeastern University, Fort Lauderdale, FL, February 8, 2001
  • “Medicare & Prescription Drugs: Year 2000 and Beyond,” AACE Corporate Advisory Board, Jacksonville, FL, February 4, 2000

Georgia

  • “U.S. Health Care: 10 Slides in 10 Minutes,” Walker School (Marietta, GA), Science Policy Class Discussion, September 8, 2021 (Virtual)
  • “Medication Development and Approval Process,” Georgia Academy of Family Physicians 53rd Annual Scientific Assembly, Atlanta, GA, December 1, 2001

Illinois

  • “The Future of the US Healthcare System,” Keynote Address to the Organization of State Medical Association Presidents, Chicago, IL, June 13, 2003

Kentucky

  • “State and National Pharmaceutical Issues,” Southeastern Socioeconomic and Family Practice Forum, Louisville, KY, August 10, 2001

Maryland

  • “Health System Reform,” MedChi (Maryland Medical Society) Health System Reform Task Force, Kent Island, MD, July 14, 2001

Massachusetts

  • Post Screening Discussion and Q&A After Showing of “Shot in the Arm” documentary about vaccine hesitancy and misinformation at Images Cinema, Williamstown, MA, May 20, 2024. Video Highlights Here
  • “Alternative Payment Models: Improving Value and Quality, or Just Adding Complexity,” Guest Lecture, UMASS School of Public Health, February 26, 2024
  • Participant, Northern Berkshires Community Coalition (nbCC) Youth Prevention Program, Site Visit with State Bureau of Substance Addiction Services (BSAS), October 18, 2022 (Virtual)
  • Improving Value with Innovations: Clinical Practice and Technologies, Guest Lecture, UMass School of Public Health, October 17, 2022
  • “From Williams Chemistry Major to Combatting Vaccine Misinformation,” Chemistry Department Career Talk, Williamstown MA, September 30, 2022
  • “Maximize Your Business Communications,” Interactive Session: 1Berkshires Technical Assistance Program, March 22, 2022 (Virtual)
  • “Patient-Centered Medical Homes,” Presentation and Discussion with Community Health Programs’ Medical Leadership Team, February 16, 2022 (Virtual)
  • “Navigating the COVID-19 Winter Surge Panel Discussion,” North Adams Chamber of Commerce, January 26, 2022 (Virtual)
  • “Career Treks: Government and Government Affairs,” Discussion Sessions with Williams College Students,” January 12, 2022 (Virtual)
  • “Adoption of Innovations: Adding Value etc.,” Guest Lecture, UMASS School of Public Health, October 20, 2021
  • “Conversation about COVID-19 and Immunizations,” Session for Boyd Technologies’ Employees, August 26, 2021
  • “Returning to Normalish: Vaccines Are Here – Now What?” Lever COVID-19 Intrapreneur Challenge Workshop, March 5, 2021
  • “COVID-19 Timelines: Vaccines and Public Health Measures,” Lever Workshop, December 10, 2020
  • “COVID-19 Timelines: Vaccines and Public Health Measures” Lever COVID-19 Intrapreneur Challenge Workshop, October 2, 2020
  • “The Road to Normalish: COVID-19 Vaccine Availability,”  Lever Angel Network, July 17. 2020 (Presentation starts at time code 2:15 and ends around 18:45)
  • “COVID-19 Vaccine Availability: The Path and Timeline to Normalish,” Lever COVID-19 Intrapreneur Challenge Workshop, June 26, 2020
  • Williams College ’68 Center for Career Exploration, “How’d You Get There” and COVID-19 Discussion, April 27, 2020
  • “Novel Coronavirus in the U.S., Data Uncertainties, Projections, and Steps for Moving Forward (or What I Think I Know),” Lever Angel Network, April 21, 2020 (Presentation is from about timepoint 4:30 to 23:15 followed by Q&A)
  • “Medicare Part D: Case Example of Federal Health Policy,” Northeastern University Health Policy Class (BHSU515), Boston, MA, March 25, 2009
  • “Health Reform 2009 and Beyond: Implications for Physicians, Patients, Hospitals, and the Economy, etc.” Caritas Carney Hospital, Boston, MA, March 11, 2009
  • “Implications of the Next Presidential Administration for Life Sciences Companies,” Yale Life Sciences Alumni Association, Boston, MA, October 21, 2008
  • “Rising Health Policy Leaders Forum,” Massachusetts General Hospital Department of Medicine, May 8, 2008
  • “AAAS Science and Technology Policy Fellowship Workshop,” Panel Presentation at AAAS Annual Meeting, Boston MA, February 16, 2008
  • “Pricing and Reimbursement as Factors for Life Science Company’s Valuation,” MIT Enterprise Forum of Cambridge’s Life Sciences Special Interest Group,” March 14, 2005
  • “Insights to Marketing: Career Advice & Professional Experiences,” Simmons Consulting Group, Simmons School of Management, Boston MA, February 14, 2005
  •  “Life Sciences Business Creation,” NETS – New Entrepreneur in Technology and Science, SHARE / Consulate of Switzerland, Cambridge MA, June 14, 2004
  • “From Idea to Reality: Turning a Lab Discovery into a Commercial Product,” Tufts University Bioengineering Center & Biomedical Engineering Department, February 27, 2004
  • “Pharmaceutical-Biotech Intellectual Property & Market Issues,” Wolf, Greenfield & Sacks, Boston, MA, June 19, 2003
  • “Public Policy and The Media: What’s the Story,” Tufts University Friedman School of Nutrition Science and Policy, NUTR0240-01: Theories of Public Policy, April 16, 2003
  • “Roles and Responsibilities of Non-Profit Boards & Board Members,” Williams College Winter Study Class, “Philanthropy and The Social Entrepreneur,” January 22, 2003
  • “The Patient and the Pharmaceutical Industry?  David and Goliath Without the Happy Ending,” 10th Annual Peter Mareb Lecture Series at Stonehill College’s Martin Institute for Law and Society, Easton, MA, April 26, 2001

Missouri

  • Testimony Before Missouri House of Representatives Interim Committee on Access to Affordable Prescription Drugs for Senior Citizens, St. Louis, MO, December 5, 2000
  • “Update on Medicare & Prescription Drugs Issues: Looking to 2001 and Beyond,” AACE Corporate Advisory Board, St. Louis, MO, November 3, 2000

New York

  • “Prescription Drug ‘Costs’,” Empire State Report’s 6th Annual Healthcare Conference, New York, NY, May 24, 2001
  • “Affordable Prescription Drugs: Why? Why Not?” Manhattan Borough-Wide Inter-Agency Council On Aging, Sixth Annual Breakfast Forum, Terence Cardinal Cooke Health Care Center, New York, NY, October 20, 2000

Oklahoma

  • “Prescription Drug Cost and Access: Pharmaceutical Industry Perspective,” Oklahoma State Medical Association 95th Annual Meeting, Saturday April 28, 2001

Oregon

  • “How to Promote Confidence in Vaccines,” OSHU School of Nursing Population Health Class, May 12, 2021

Pennsylvania

Rhode Island

  • “Healthcare Policy & Politics,” Brown University Department of Political Science and Public Policy, “PS 110: Congress and Public Policy,” March 6, 2003

Tennessee

  • “Trends and Treatments in Women’s Health,” Keynote Address, Senior Women’s Health Forum Baptist Hospital, Nashville, TN, June 8, 2000

Texas

  • “The Production of Pharmaceuticals Overseas:  Implications for US Physicians and Patients,” American Association of Clinical Endocrinologists (AACE) Corporate Advisory Board, San Antonio, TX, May 2, 2001
  • “Walking the Tightrope: Stretching the Pharmacy Dollar,” Panel, Texas Pharmacy Association Annual Meeting, Austin, TX, June 23, 2000
  • “Overview of the Pharmaceutical Market – Prescription Drugs & Healthcare: Year 2000 and Beyond,” HMO Alliance Board of Directors Meeting, Dallas, TX, February 24, 2000

Vermont

  • “Access: What is Being Done,” BlueCross BlueShield of Vermont and The Vermont Health Plan Meeting on “Understanding the Cost of Drugs,” Burlington, VT, October 24, 2000
  • “Reaction Panel:  An In-Depth Look at Price,” BlueCross BlueShield of Vermont and The Vermont Health Plan Meeting on “Understanding the Cost of Drugs,” Burlington, VT, October 24, 2000
  • ”What Can Be Done to Reduce Prescription Drug Bills Now?” Community Forum Hosted by Vermont State Representatives Margaret Flory, Kevin Mullin and Thomas Depoy, Godnick Adult Center, Rutland, VT, October 17, 2000

Virginia

  • “Health, Healthcare, and Government Budgets,” George Mason University, Schar School of Policy and Government, September 29, 2016
  • “Health Reform and Fiscal Challenges: Health Policy is Budget Policy (and Political Policy),” George Mason University School of Policy, Government and International Affairs, February 18, 2016
  • “Health Reform and Fiscal Challenges: Health Policy is Budget Policy,” George Mason University School of Policy, Government and International Affairs, February 19, 2015
  • “Government Financial Policy: Health & Healthcare,” George Mason University School of Policy, Government and International Affairs, September 23, 2014
  • “State Level Health Transformation: Factors and Visions,” George Mason University School of Public Policy, June 30, 2014
  • “Government Fiscal Issues: Healthcare,” University of Virginia Batten School of Public Policy, February 18, 2013
  • “Medicare and Obamacare,” The Envoy, Alexandria VA, October 10, 2012
  • “A Conversation on President Obama’s Health Care Policies,” Commonwealth Healthcare and Rehab, Fairfax VA, October 9, 2012
  • “Discussion of Healthcare, Medicare, Medicaid and Social Security Policies,” Woodbine Rehabilitation & Healthcare, Alexandria, VA, October 8, 2012
  • “Changes to Medicare and the Election,” The Hermitage, Alexandria VA, October 5, 2012
  • “A Conversation on President Obama’s Health Care Policies,” ManorCare, Arlington VA, October 3, 2012
  • “A Conversation on President Obama’s Health Care Policies,” The Woodlands, Fairfax VA, October 3, 2012
  • “Value in Healthcare: Unraveling the Equation,” Virginia Association of Health Underwriters, Richmond, VA, April 23, 2002
  • “What Can We Do About Drug Costs?,” Panel Discussion at Central Shenandoah Valley Health Care Coalition Annual Seminar “Employers’ Perspectives on Health Care Costs: Nowhere But Up?,” Staunton, VA, December 1, 2000
  • “Medicare & Prescription Drugs:  2000 and Beyond,” Virginia Quality Healthcare Network, Richmond, VA, May 12, 2000

Washington

  • “Prescription Drug: How Can We Balance Care, Costs and Access?,” The O’Connor Report Invitational Healthcare Leadership Forum, Seattle, WA, June 1, 2001

Print Friendly, PDF & Email